Sp 4 - analogs
| Prices in pharmacies: Instructions Sp 4 | |||||||||
|
ⓘ✘Enter drugs for checking interactions through a quick button search . Bromdihydrochlorphenylbenzodiazepine ✘ (incl) Azilsartan medoxomil ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. | ||||||
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
- 44% Sp 6 neutral
- 39% Sp 3 neutral
- 39% St 42 neutral
- 35% St 40 neutral
- 29% St 36 neutral
- 28% Tb 5 neutral
- 28% Ren 4 neutral
- 28% St 44 neutral
- 27% Kid 3 neutral
- 27% P 6 neutral
- 25% Bl 17 neutral
- 25% P 5 neutral
- 24% Ren 12 neutral
- 24% Liv 14 neutral
- 24% L.i. 6 neutral
- 24% Sp 1 neutral
- 24% Sp 5 neutral
- 23% Kid 4 neutral
- 23% St 45 neutral
- 23% St 37 neutral
- 22% P 7 neutral
- 22% Liv 13 neutral
- 19% Gb 34 neutral
- 18% L.i. 11 neutral
- 18% Bl 58 neutral
- 18% Bl 64 neutral
- 18% Liv 3 neutral
- 17% L.i. 4 neutral
- 17% Kid 7 neutral
- 17% Sp 2 neutral
- 17% Bl 20 neutral
- 17% P 8 neutral
- 16% Kid 2 neutral
- 15% Liv 2 neutral
- 15% Gb 39 neutral
- 15% Kid 10 neutral
- 15% Lu 5 neutral
- 15% St 41 neutral
- 15% Kid 6 neutral
- 15% Lu 9 neutral
- 14% Iu 7 neutral
- 14% Du 20 neutral
- 14% Ren 6 neutral
- 14% Bl 18 neutral
- 14% Sp 8 neutral
- 13% Ren 1 neutral
- 13% Liv 8 neutral
- 13% Ren 3 neutral
- 12% Tb 6 neutral
- 12% He 7 neutral
Learn more about the selection of analogues
- The drug has «Sp 4» no complete analogues; 51 analog by action, the most similar - Sp 6 .
- Medical online service has selected the best substitutes for Sp 4 based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of analogues Sp 4 to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.